Access the full text.
Sign up today, get DeepDyve free for 14 days.
FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, L Paz-Ares (2017)
Lung cancer: current therapies and new targeted treatmentsLancet, 389
Y. Bing (2007)
Clinical Study on the Treatment of Advanced NSCLC with Shengmai Injection Combined with ChemotherapyJournal of Anhui Traditional Chinese Medical College
Q Li, H Liu (2005)
Pharmacological action and clinical application of Shengmai injectionMed Recapitulate, 11
XA Lu (2011)
Effect of Shengmai injection combined with chemotherapy on the quality of life and immune function in patients with advanced non-small cell lung cancerShaanxi J Tradit Chin Med, 32
C. Schag, R. Heinrich, P. Ganz (1984)
Karnofsky performance status revisited: reliability, validity, and guidelines.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2 3
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
METHODS OF SYSTEMATIC REVIEWS AND META-ANALYSIS Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
QS Chen, Y Chen, ZJ Yang, JB Liu, RQ Pei (2011)
The effect on quality of life to advanced stage non-small cell lung cancer patient treated with Shengmai injection combined chemotherapyChina J Chin Med, 26
CW Liang (2007)
Clinical study on the treatment of advanced NSCLC with Shengmai injection combined with chemotherapyJ Anhui TCM Coll, 26
JY Liu, BY Liu, Y Liu (2014)
Clinical efficacy of Shengmai injection combined with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancerChina J Pharm Econ, 9
ZJ Yang, CM Deng, YH Qiu, BS Mo (2012)
Shengmai injection combined with NP regimen in the treatment of 30 cases of advanced non-small cell lung cancerWorld Health Dig Med Periodieal, 9
E. Mannion, J. Gilmartin, P. Donnellan, M. Keane, D. Waldron (2014)
Effect of chemotherapy on quality of life in patients with non-small cell lung cancerSupportive Care in Cancer, 22
Yi Jiang, Ling-Shuang Liu, L. Shen, Zhi-fen Han, H. Jian, Jiaxiang Liu, LingnLing Xu, He-gen Li, Jianhui Tian, Zhujun Mao (2016)
Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial.Complementary therapies in medicine, 24
YH Bao (2011)
Effect of Shengmai injection on the quality of life of patients with advanced non-small cell lung cancer receiving chemotherapyChin J Clin Res, 24
D. Ettinger, D. Wood, D. Aisner, W. Akerley, J. Bauman, L. Chirieac, T. D’amico, M. Decamp, T. Dilling, M. Dobelbower, R. Doebele, R. Govindan, M. Gubens, M. Hennon, L. Horn, R. Komaki, R. Lackner, M. Lanuti, T. Leal, Leah Leisch, R. Lilenbaum, Jules Lin, B. Loo, R. Martins, G. Otterson, K. Reckamp, Gregory Riely, S. Schild, T. Shapiro, J. Stevenson, S. Swanson, K. Tauer, Stephen Yang, K. Gregory, M. Hughes (2017)
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncologyJournal of The National Comprehensive Cancer Network, 15
J. Molina, Ping Yang, S. Cassivi, S. Schild, A. Adjei (2008)
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.Mayo Clinic proceedings, 83 5
GX Li (2005)
Clinical observation of Shengmai injection combined with chemotherapy in the treatment of advanced non-small cell lung cancerJETCM, 14
R. Siegel, K. Miller, A. Jemal (2015)
Cancer statistics, 2015CA: A Cancer Journal for Clinicians, 65
Zhao-xu Zheng (2007)
Clinical observation of shengmai injection combined chemotherapy in advanced lung cancerJournal of Modern Oncology
Wang Qing-cai (2006)
Shengmai Injection Plus Combined with Gemcitabine Plus Cisplatin Cure Advanced NSCLCSuzhou University Journal of Medical Science
CM Zhang (2016)
Effect of Shengmai injection combined with chemotherapy in the treatment of patients with advanced non-small cell lung cancerChin Prim Health Care, 30
GF Zhou, AJ Li (2003)
Shengmai injection treatment for chemotherapy-reduced adverse reaction in non-small cell lung cancer 30 cases of patientsCJITWM, 23
(2021)
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
S. Shojaee, P. Nana-Sinkam (2017)
Recent advances in the management of non-small cell lung cancerF1000Research, 6
Hangyu Yuan (2009)
The VEGF levels after pulse-activating ingection combined with interventional chemotherapy for non-small cell lung cancerJournal of Xinjiang Medical University
DJ Wang (2012)
Efficacy of Shengmai injection combined with TP regimen in the treatment of advanced non-small cell lung cancerJilin Med J, 33
A. Miller, B. Hoogstraten, M. Staquet, A. Winkler (1981)
Reporting results of cancer treatmentCancer, 47
S. Ramalingam, C. Belani (2002)
Doublet chemotherapy for advanced non-small cell lung cancer.Clinical lung cancer, 4 1
QH Zhang (2008)
Clinical observation of adjunctive treatment with Shengmai injection in non small cell lung cancerMod J Integr Tradit Chin West Med, 17
Q Wu, X He (2012)
Clinical observation of Shengmai injection combined with chemotherapy in the treatment of middle to advanced lung cancerChin J Tradit Med Sci Technol, 19
L. Jiao, Changsheng Dong, Jiaxiang Liu, Zhiwei Chen, Lei Zhang, Jian-fang Xu, Xiaoyong Shen, J. Che, Yi Yang, Hai Huang, He-gen Li, Jianli Sun, Yi Jiang, Zhujun Mao, Peiqi Chen, Yabin Gong, Xiaolin Jin, LingnLing Xu (2017)
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer PatientsScientific Reports, 7
D Moher, A Liberati, J Tetzlaff, DG Altman (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med, 151
Yan Han, Huan Wang, Wei-ru Xu, B. Cao, Lei Han, L. Jia, Yongmei Xu, Qing Zhang, Xiaomin Wang, Ganlin Zhang, Mingwei Yu, Guowang Yang (2016)
Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients.Complementary therapies in medicine, 24
Purpose Shengmai injection (SMI) has shown promising outcomes in the management of non-small cell lung cancer (NSCLC). This meta-analysis aimed to investigate the add-on effects of SMI to chemotherapy in NSCLC patients. Methods A comprehensive literature search was performed in the Cochrane Library, PubMed, Embase, CNKI, VIP, and Wanfang up to December 2017. Only randomized controlled trials (RCTs) evaluating SMI in combination with chemotherapy versus chemotherapy alone in NSCLC patients were eligible. The outcome measures were quality of life, chemotherapy-induced grade 3/4 myelosuppression or gastrointestinal reactions, and objective tumor response (equals complete response plus partial response). Pooled risk ratio (RR) with 95% confidence interval (CI) was used to evaluate dichotomous and continuous outcome, respectively. Results A total of 15 RCTs were included and analyzed. Meta-analysis showed that SMI combined with chemotherapy was associated with a significant improvement in Karnofsky Performance Status (RR 2.36; 95% CI 1.50–3.96) compared with the chemotherapy alone. Moreover, adjunctive treatment with SMI significantly reduced grade 3/4 myelosuppression (RR 0.61; 95% CI 0.46–0.81) and gastrointestinal reactions (RR 0.64; 95% CI 0.46–0.90). However, there was no significant difference in objective tumor response (RR 1.17; 95% CI 0.99–1.37) between two groups. Conclusions SMI add-on therapy appeared to be
Supportive Care in Cancer – Springer Journals
Published: Mar 29, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.